Manchester Management Co LLC's Form 4 filing
Modular Medical, Inc. (MODD) · filed Mar 24, 2025
- Accession no.
- 0000919574-25-002089
- Filed
- Mar 24, 2025, 9:34 PM ET
- Trade date
- Mar 20, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 2 derivative transactions. Open-market purchases total $1.30M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Manchester Management Co LLCCIK 0001169253 | Director, Officer (Chief Executive Officer), 10% Owner, Other: Director by Deputization |
| Besser James ECIK 0001512127 | Officer (Chief Executive Officer), 10% Owner |
| Frank Morgan C.CIK 0001593072 | Director |
| JEB Partners, L.P.CIK 0001093241 | Other: Director by Deputization |
| Manchester Explorer, L.P.CIK 0001411524 | Other: Director by Deputization |
| Manchester Management PR, LLCCIK 0001735534 | Other: Director by Deputization |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 20, 2025 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +520,832 | $1.92 | +$999,997.44 | 3,805,575 | Indirect | |
| Mar 20, 2025 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +156,250 | $1.92 | +$300,000 | 422,000 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 20, 2025 | Common Stock, par value $0.001 per share | AGrant or awardAcquired | +260,416 | $1.12 | +$291,665.92 | 260,416 | Indirect | |
| Mar 20, 2025 | Common Stock, par value $0.001 per share | AGrant or awardAcquired | +78,125 | $1.12 | +$87,500 | 78,125 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.